title: Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.
abstract: BACKGROUND
  Earlier studies have reported the production of histamine in colorectal cancers (CRCs). The effect of histamine is largely determined locally by the histamine receptor expression pattern. Recent evidence suggests that the expression level of histamine receptor H4 (HRH4) is abnormal in colorectal cancer tissues. However, the role of HRH4 in CRC progression and its clinical relevance is not well understood. The aim of this study is to evaluate the clinical and molecular phenotypes of colorectal tumors with abnormal HRH4 expression.
  
  
  METHODS
  Immunoblotting, real-time PCR, immunofluorescence and immunohistochemistry assays were adopted to examine HRH4 expression in case-matched CRC samples (n = 107) and adjacent normal tissues (ANTs). To assess the functions of HRH4 in CRC cells, we established stable HRH4-transfected colorectal cells and examined cell proliferation, colony formation, cell cycle and apoptosis in these cells.
  
  
  RESULTS
  The protein levels of HRH4 were reduced in most of the human CRC samples regardless of grade or Dukes classification. mRNA levels of HRH4 were also reduced in both early-stage and advanced CRC samples. In vitro studies showed that HRH4 over-expression caused growth arrest and induced expression of cell cycle proteins in CRC cells upon exposure to histamine through a cAMP -dependent pathway. Furthermore, HRH4 stimulation promoted the 5-Fu-induced cell apoptosis in HRH4-positive colorectal cells.
  
  
  CONCLUSIONS
  The results from the current study supported previous findings of HRH4 abnormalities in CRCs. Expression levels of HRH4 could influence the histamine-mediated growth regulation in CRC cells. These findings suggested a potential role of abnormal HRH4 expression in the progression of CRCs and provided some new clues for the application of HRH4-specific agonist or antagonist in the molecular therapy of CRCs.
authors: Biomedical Research Institute, Shenzhen-PKU-HKUST Medical Center, Guangdong Province, Shenzhen, China.
authors: Zhengyu
authors: Z
authors: Fang
authors: Wantong
authors: W
authors: Yao
authors: Yi
authors: Y
authors: Xiong
authors: Jiana
authors: J
authors: Li
authors: Li
authors: L
authors: Liu
authors: Lei
authors: L
authors: Shi
authors: Wei
authors: W
authors: Zhang
authors: Chao
authors: C
authors: Zhang
authors: Liping
authors: L
authors: Nie
authors: Jun
authors: J
authors: Wan
references: Inflamm Res. 2005 Apr;54 Suppl 1:S80-1
references: 15928846
references: Eur J Surg. 1991 Aug;157(8):437-41
references: 1681927
references: Agents Actions. 1988 Apr;23(3-4):357-60
references: 3394588
references: J Pharmacol Exp Ther. 2003 Jun;305(3):1212-21
references: 12626656
references: Eur J Surg Oncol. 1997 Jun;23(3):224-7
references: 9236896
references: Cancer Biol Ther. 2008 Jan;7(1):28-35
references: 17932461
references: Leuk Lymphoma. 2000 Jan;36(3-4):367-73
references: 10674909
references: Eur J Cell Biol. 2008 Apr;87(4):227-36
references: 18258331
references: Inflamm Res. 2008;57 Suppl 1:S23-4
references: 18345506
references: Semin Oncol. 2005 Feb;32(1):61-8
references: 15726507
references: Cancer Nurs. 2007 Jul-Aug;30(4 Suppl 1):S1-9
references: 17666985
references: Gut. 2006 Apr;55(4):498-504
references: 16299042
references: Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6807-15
references: 16203768
references: Agents Actions. 1994 Jun;41 Spec No:C118-20
references: 7976795
references: Am J Surg. 2009 Aug;198(2):244-9
references: 19628063
references: Br J Pharmacol. 2003 Nov;140(6):1117-27
references: 14530216
references: Int J Colorectal Dis. 2004 Nov;19(6):510-7
references: 14999511
references: Apoptosis. 2007 Jan;12(1):235-46
references: 17136318
references: Biochem Pharmacol. 1999 Jun 15;57(12):1341-4
references: 10353253
references: Genes Dev. 1999 Jun 15;13(12):1501-12
references: 10385618
references: Inflamm Res. 2001 Apr;50 Suppl 2:S102-3
references: 11411574
references: J Pharmacol Exp Ther. 2010 Mar;332(3):730-7
references: 20008488
references: Cancer Res. 1979 Dec;39(12):4914-24
references: 498117
references: Cancer Res. 1989 Dec 1;49(23):6543-6
references: 2819710
references: Inflamm Res. 2004 Mar;53 Suppl 1:S87-8
references: 15054633
references: Exp Cell Res. 1999 Oct 10;252(1):211-23
references: 10502413
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Dig Dis Sci. 2001 Oct;46(10):2187-98
references: 11680595
references: Oncol Res. 2000;12(5):231-9
references: 11417748
references: Nat Med. 1996 Apr;2(4):364-5
references: 8597928
references: Clin Cancer Res. 2000 Mar;6(3):1113-8
references: 10741741
references: Ai Zheng. 2005 Sep;24(9):1161-4
references: 16159447
references: PLoS One. 2009 Aug 07;4(8):e6504
references: 19662098
references: Clin Cancer Res. 1999 May;5(5):1057-62
references: 10353738
references: Cancer. 2005 Jun 15;103(12):2435-46
references: 15880563
references: Immunology. 2007 Jun;121(2):266-75
references: 17346280
references: Discov Med. 2011 Feb;11(57):95-105
references: 21356164